NDC 55513-209 – Neupogen
Filgrastim 480 ug/.8mL · Injection, Solution · Intravenous, Subcutaneous
Product NDC55513-209
Product details
- Brand name
- Neupogen
- Generic name
- Filgrastim
- Labeler
- Amgen, Inc
- Dosage form
- Injection, Solution
- Route
- Intravenous, Subcutaneous
- Marketing category
- BLA · BLA103353
- Marketed since
- October 2, 2000
- Listing expires
- December 31, 2027
- Pharmacologic class
- Leukocyte Growth Factor
Active ingredients
- Filgrastim 480 ug/.8mL
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 55513-209-10 | 10 SYRINGE in 1 BOX (55513-209-10) / .8 mL in 1 SYRINGE (55513-209-01) | Oct 2, 2000 |
| 55513-209-20 | 10 SYRINGE in 1 BOX (55513-209-20) / .8 mL in 1 SYRINGE (55513-209-01) | Oct 1, 2025 |
| 55513-209-91 | 1 SYRINGE in 1 BOX (55513-209-91) / .8 mL in 1 SYRINGE | Oct 2, 2000 |
Recalls mentioning this NDC
- D-0285-2025 Mar 26, 2025 · Class II
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months. - D-0286-2025 Mar 26, 2025 · Class II
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.